CADUCEUS, SCIPIO, ALCADIA: Cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

25 citing papers in PubMed.

1. Epicardium-Derived Tbx18Frontiers in cardiovascular medicine · 2021
   Article
2. Locoregional delivery of stem cell-based therapies.Science translational medicine · 2020
   Review
3. Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials.Cells · 2019
   Review
4. The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy.Current cardiology reports · 2018
   Review
5. Cardiac Progenitor Cells: The Matrix Has You.Stem cells translational medicine · 2018
   Article
6. Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine.Stem cells international · 2018
   Review
7. Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease.PeerJ · 2018
   Article
8. Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration.Stem cells international · 2018
   Review
9. Recent Progress in Stem Cell Modification for Cardiac Regeneration.Stem cells international · 2018
   Review
10. Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up.Journal of cardiovascular translational research · 2017
    Review
11. Cardiac regenerative medicine: At the crossroad of microRNA function and biotechnology.Non-coding RNA research · 2017
    Review
12. Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells.Frontiers in cardiovascular medicine · 2017
    Review
13. Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed.Stem cells international · 2017
    Review
14. Normal versus Pathological Cardiac Fibroblast-Derived Extracellular Matrix Differentially Modulates Cardiosphere-Derived Cell Paracrine Properties and Commitment.Stem cells international · 2017
    Article
15. Pim1 Kinase Overexpression Enhances ckitJournal of the American College of Cardiology · 2016
    Article
16. Physiological and hypoxic oxygen concentration differentially regulates human c-Kit+ cardiac stem cell proliferation and migration.American journal of physiology. Heart and circulatory physiology · 2016
    Article
17. Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Review
18. Can heart function lost to disease be regenerated by therapeutic targeting of cardiac scar tissue?Seminars in cell & developmental biology · 2016
    Review
19. Cardiac Repair and Regeneration: The Value of Cell Therapies.European cardiology · 2016
    Article
20. Foetal bovine serum-derived exosomes affect yield and phenotype of human cardiac progenitor cell culture.BioImpacts : BI · 2016
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.